ACHV Insider Trading Activity and SEC Form 4 Filings
ACHV insider trading summary
Over the past 12 months, insiders at Achieve Life Sciences, Inc. (ACHV) reported 1 sale worth $175K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $175K.
Latest ACHV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Richard Alistair Stewart | Insider | Sell | $175K (20,626 @ $8.49) |
| Sep 18, 2025 | Mark K Oki | Chief Financial Officer | Sell | $146K (50,060 @ $2.92) |
| Sep 18, 2025 | Richard Alistair Stewart | Chief Executive Officer | Sell | $378K (129,501 @ $2.92) |
| Sep 4, 2025 | Cindy Jacobs | President & CMO | Sell | $77K (27,629 @ $2.77) |
| Sep 4, 2025 | Jerry Wan | Principal Accounting Officer | Sell | $39K (14,070 @ $2.77) |
| Sep 4, 2025 | Thomas Braxton King | Insider | Sell | $387K (139,858 @ $2.77) |
| Sep 4, 2025 | Jaime Xinos | Chief Commercial Officer | Sell | $58K (20,854 @ $2.77) |
| Mar 17, 2025 | Mark K Oki | Chief Financial Officer | Buy | $29K (10,000 @ $2.89) |
| Mar 17, 2025 | Richard Alistair Stewart | Chieve Executive Officer | Buy | $29K (10,000 @ $2.86) |
| Mar 4, 2024 | Richard Alistair Stewart | Executive Chairman | Buy | $46K (10,000 @ $4.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.